Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Verschueren · SciRah

Researcher profile · Semantic Scholar

P. Verschueren

Share profile

P. Verschueren — researcher profile on SciRah

h-index: 36
Works: 403
Citations: 6,668

Most-cited papers

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.
J. Smolen, Christopher J. Edwards, V. Konzett, F. Laskou +46 more
2026Annals of the Rheumatic Diseases89 citations Open access
Semantic Scholar
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)
R. Aymon, D. Mongin, S. A. Bergstra, D. Choquette +25 more
2023Annals of the Rheumatic Diseases26 citations Open access
Semantic Scholar
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
C. V. D. van der Togt, B. V. D. van den Bemt, D. Aletaha, R. Alten +9 more
2023RMD Open25 citations Open access
Semantic Scholar
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.
J. Vulsteke, V. Smith, C. Bonroy, R. Derua +11 more
2023Journal of Autoimmunity21 citations
Semantic Scholar
Lung ultrasound outperforms symptom-based screening to detect interstitial lung disease associated with rheumatoid arthritis
M. Vermant, A. Kalkanis, Joseph Jacob, Tinne Goos +11 more
2025RMD Open20 citations Open access
Semantic Scholar
TET2-Driver and NLRC4-Passenger Variants in Adult-Onset Autoinflammation.
E. De Langhe, S. Van Loo, B. Malengier-Devlies, Mieke Metzemaekers +14 more
2023New England Journal of Medicine20 citations Open access
Semantic Scholar
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis
Marianne A. Messelink, A. D. den Broeder, Florine E. Marinelli, Edwin Michgels +4 more
2023RMD Open18 citations Open access
Semantic Scholar
Classification of rheumatoid arthritis: is it time to revise the criteria?
G. Steiner, P. Verschueren, L. van Hoovels, P. Studenic +1 more
2024RMD Open16 citations Open access
Semantic Scholar
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?
L. van Ouwerkerk, P. Verschueren, M. Boers, P. Emery +7 more
2023Annals of the Rheumatic Diseases15 citations Open access
Semantic Scholar
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
Luna Dillemans, Karen Yu, A. De Zutter, Sam Noppen +13 more
2024Cell Communication and Signaling12 citations Open access
Semantic Scholar
Integrating pretest probability for rheumatoid arthritis with likelihood ratios of RF and ACPA to improve clinical utility of rheumatoid arthritis autoantibody testing.
D. Vandebeek, Elke Lodewijckx, L. van Hoovels, P. Verschueren +1 more
2024Clinica chimica acta; international journal of clinical chemistry11 citations
Semantic Scholar
Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis
C. Triaille, P. Quartier, L. De Somer, P. Durez +4 more
2023Rheumatology11 citations Open access
Semantic Scholar
Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis
Karen Yu, Luna Dillemans, M. Gouwy, Helena Bessa +8 more
2023Frontiers in Immunology11 citations Open access
Semantic Scholar
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.
F. Laskou, V. Konzett, J. Smolen, Christopher J. Edwards +14 more
2026Annals of the Rheumatic Diseases10 citations Open access
Semantic Scholar
Ultrasonographic Presentation and Anatomic Distribution of Lung Involvement in Patients with Rheumatoid Arthritis
M. Vermant, A. Kalkanis, Tinne Goos, H. Cypers +5 more
2023Diagnostics10 citations Open access
Semantic Scholar
Definitions of rheumatoid arthritis flare and how they relate to patients' perspectives: A scoping review of qualitative and quantitative evidence.
M. Doumen, Lotte Diricks, Joppe Hermans, D. Bertrand +3 more
2024Seminars in Arthritis & Rheumatism8 citations Open access
Semantic Scholar
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis.
V. Konzett, F. Laskou, J. Smolen, Christopher J. Edwards +14 more
2026Annals of the Rheumatic Diseases7 citations Open access
Semantic Scholar
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
R. Westhovens, K. Winthrop, A. Kavanaugh, Maria Greenwald +10 more
2025RMD Open7 citations Open access
Semantic Scholar
Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act!
M. Doumen, S. Pazmino, P. Verschueren, René Westhovens
2023Rheumatology7 citations Open access
Semantic Scholar
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial
D. Bertrand, J. Joly, B. Neerinckx, P. Durez +25 more
2024RMD Open6 citations Open access
Semantic Scholar
Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)
M. Doumen, E. De Meyst, C. Lefèvre, S. Pazmino +5 more
2023Trials6 citations Open access
Semantic Scholar
Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation.
M. Doumen, V. Stouten, S. Pazmino, E. De Meyst +4 more
2023Rheumatology6 citations Open access
Semantic Scholar
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study
J. Geldof, M. Truyens, J. Sabino, M. Ferrante +9 more
2023Frontiers in Immunology6 citations Open access
Semantic Scholar
Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naïve early psoriatic arthritis
A. Ishchenko, M. Van Mechelen, Lies Storms, K. de Vlam +4 more
2025RMD Open5 citations Open access
Semantic Scholar
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive protein
A. Ishchenko, M. Van Mechelen, S. Pazmino, Lies Storms +4 more
2025RMD Open5 citations Open access
Semantic Scholar
A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomised controlled AEGORA trial.
M. Doumen, E. De Meyst, D. Bertrand, S. Pazmino +5 more
2024Rheumatology5 citations Open access
Semantic Scholar
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
Maya H. Buch, D. Aletaha, Bernard Combe, Yoshiya Tanaka +11 more
2024RMD Open5 citations Open access
Semantic Scholar
AB0421 REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
D. C. Diederik, P. Durez, J. Lenaerts, R. Westhovens +1 more
2023Annals of the Rheumatic Diseases5 citations Open access
Semantic Scholar
Are genes the missing link to detect and prognosticate RA-ILD?
M. Vermant, Tinne Goos, S. Gogaert, D. De Cock +2 more
2023Rheumatology Advances in Practice5 citations Open access
Semantic Scholar
Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.
V. Konzett, F. Laskou, J. Smolen, Christopher J. Edwards +14 more
2026Annals of the Rheumatic Diseases3 citations Open access
Semantic Scholar
Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data
D. Bertrand, E. De Meyst, M. Doumen, D. De Cock +7 more
2025BMC Rheumatology3 citations Open access
Semantic Scholar
To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis
D. Bertrand, Anke Deprez, M. Doumen, D. De Cock +8 more
2024Therapeutic Advances in Musculoskeletal Disease3 citations Open access
Semantic Scholar
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells
K. Covens, B. Verbinnen, Britt G. de Jong, Leen Moens +13 more
2023Frontiers in Immunology3 citations Open access
Semantic Scholar
The prevalence of interstitial lung disease in rheumatoid arthritis: a systematic review
M. Vermant, Thomas P. C. Pauwels, T. Follet, L. D. De Sadeleer +5 more
2026Rheumatology Advances in Practice2 citations Open access
Semantic Scholar
Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study
L. Fierens, S. Coenen, J. Joly, T. Vanhoutvin +9 more
2024Infectious Diseases2 citations
Semantic Scholar
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis
P. Vandormael, S. Fadlallah, P. Ruytinx, A. Pues +8 more
2024RMD Open2 citations Open access
Semantic Scholar
Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA)
E. De Meyst, D. Bertrand, J. Joly, M. Doumen +5 more
2024Trials2 citations Open access
Semantic Scholar
The future of polymyalgia rheumatica research: what can we learn from rheumatoid arthritis?
L. Moreel, M. Doumen, A. Betrains, D. Blockmans +2 more
2023Joint Bone Spine2 citations Open access
Semantic Scholar
OP0129 EFFECTIVENESS OF COBRA-SLIM WITH OR WITHOUT EARLY ACCESS TO A TEMPORARY 6-MONTH COURSE OF ETANERCEPT IN EARLY RA: PRIMARY OUTCOME OF THE 2-YEAR, PRAGMATIC, RANDOMISED CARERA2020 TRIAL
D. Bertrand, J. Joly, B. Neerinckx, P. Durez +23 more
2023Annals of the Rheumatic Diseases2 citations Open access
Semantic Scholar
Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis.
M. Vermant, V. Van Ballaer, Joseph Jacob, T. Follet +12 more
2026Arthritis & Rheumatology1 citations Open access
Semantic Scholar
The positive perspective paradigm: proposal of a model to mitigate the impact of chronic inflammatory arthritis through comprehensive and early intervention.
M. Doumen, L. Gossec, Mwidimi Ndosi, P. Taylor +3 more
2026Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
POS0578 REAL-WORLD EFFECTIVENESS OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED FOR UP TO 2 YEARS IN CLINICAL PRACTICE: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
P. Verschueren, R. Bos, G. Burmester, A. Escudero-Contreras +6 more
2025Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)
J. Geldof, M. Truyens, J. Sabino, Marc Ferrante +9 more
2024Vaccines1 citations Open access
Semantic Scholar
Skin infections caused by Mycobacterium chelonae: Underestimated, especially in immunocompromised patients
Celine De Krock, Otto Van de Gaer, Emmanuel André, J. Lenaerts +3 more
2024JEADV Clinical Practice1 citations Open access
Semantic Scholar
OP0287-HPR ONE-IN-THREE PATIENTS WITH RHEUMATOID ARTHRITIS REPORT CLINICALLY IMPORTANT WORSENING ON THE RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) BETWEEN CLINIC VISITS: ENGAGEMENT AND PATIENT-REPORTED OUTCOME RESULTS FROM A SMARTPHONE APP FOR PATIENT EDUCATION AND REMOTE MONITORING
M. Doumen, E. De Meyst, M. Piessens, D. Bertrand +5 more
2024Health Professionals in Rheumatology Abstracts1 citations
Semantic Scholar
Individuals with ACPA-negative clinically suspect arthralgia experience more symptom burden: is seronegative disease truly less severe?
M. Doumen, René Westhovens, P. Verschueren
2024Rheumatology1 citations Open access
Semantic Scholar
Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis.
D. Bertrand, Anke Deprez, M. Doumen, D. De Cock +8 more
2024Musculoskeletal Care1 citations Open access
Semantic Scholar
AB0569 PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB FOR UP TO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
J. Avouac, G. Burmester, R. Caporali, T. Debray +7 more
2024Scientific Abstracts1 citations
Semantic Scholar
AB0525 EARLY RESPONDERS TO REMISSION-INDUCTION TREATMENT WITH METHOTREXATE AND BRIDGING GLUCOCORTICOIDS REPORT LOWER RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) OVER 2 YEARS: SECONDARY ANALYSIS OF THE CARERA2020 TRIAL
M. Doumen, D. Bertrand, J. Joly, E. De Meyst +3 more
2024Scientific Abstracts1 citations
Semantic Scholar
POS0658 LONG-TERM EFFICACY OF FILGOTINIB MONOTHERAPY AND COMBINATION THERAPY: INTERIM RESULTS FROM A POST HOC ANALYSIS OF THE FINCH 4 STUDY
M. Buch, P. Verschueren, R. Caporali, T. Huizinga +5 more
2024Scientific Abstracts1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Doumen×16
Invite
M. Doumen — researcher profile on SciRah
D. Bertrand×13
Invite
D. Bertrand — researcher profile on SciRah
S. Pazmino×13
Invite
S. Pazmino — researcher profile on SciRah
E. De Meyst×12
Invite
E. De Meyst — researcher profile on SciRah

×12

Invite

J. Joly — researcher profile on SciRah

René Westhovens×11

Invite

René Westhovens — researcher profile on SciRah

Invite

D. Aletaha — researcher profile on SciRah

Invite

R. Caporali — researcher profile on SciRah

B. Neerinckx×8

Invite

B. Neerinckx — researcher profile on SciRah

Invite

K. Hyrich — researcher profile on SciRah

Tsutomu Takeuchi×5

Invite

Tsutomu Takeuchi — researcher profile on SciRah

Invite

D. De Cock — researcher profile on SciRah